Tumor necrosis factor-α antagonism by the murine tumor necrosis factor-α receptor 2-Fc fusion protein exacerbates histoplasmosis in mice

Journal of Interferon and Cytokine Research

Volumn 27, Issue 6, 2007, Pages 471-480

  Deepe Jr , George S ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G1; INDUCIBLE NITRIC OXIDE SYNTHASE; PROTEIN P75; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; TUMOR NECROSIS FACTOR ALPHA RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA RECEPTOR 2 FC FUSION PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BACTERIAL IMMUNITY; CONTROLLED STUDY; DRUG EFFICACY; HISTOPLASMA CAPSULATUM; HISTOPLASMOSIS; INFLAMMATORY DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; CYTOKINES; DISEASE PROGRESSION; GENE EXPRESSION REGULATION; HISTOPLASMA; HISTOPLASMOSIS; IMMUNOGLOBULIN FC FRAGMENTS; INFLAMMATION; MICE; MICE, INBRED C57BL; NITRIC OXIDE SYNTHASE TYPE II; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; RECOMBINANT PROTEINS; SURVIVAL RATE; TUMOR NECROSIS FACTOR-ALPHA;

AJELLOMYCES CAPSULATUS; MURINAE; MUS;

EID: 34250863792     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2007.0178     Document Type: Article

References (25)

1. Anderson PJ. Tumor necrosis factor inhibitors: clinical implications of their different immunogenicity profiles. Semin. Arthritis Rheum. 2005:34:19-22.
2. Beutler B, Cerami A. The biology of cachectin/TNF - α primary mediator of the host response. Annu. Rev. Immunol. 1989;7: 625-655.
3. Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, Siegel JN, Braun MM. Tuberculosis associated with infliximab, a tumor necrosis factor-α-neutralizing agent. N. Engl. J. Med. 2001;345:1098-1104.
4. Lee JH, Slifman NR, Gershon SK, Edwards ET, Schwieterman WD, Siegel JN, Wise RP, Brown SL, Udall JN Jr, Braun MM. Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor a antagonists infliximab and etanercept. Arthritis Rheum. 2002;46:2565-2570.
5. Wallis RS, Broder MS, Wong JY, Hanson ME, Beenhouwer DO. Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin. Infect. Dis. 2004;38:1261-1265.
6. Deepe GS Jr. Histoplasma capsulatum. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practices of Infectious Diseases. 6th ed. Philadelphia: Elsevier Churchill Livingstone, 2004:3012-3026.
7. Allendoerfer R, Deepe GS Jr. Blockade of endogenous TNF-α exacerbates primary and secondary pulmonary histoplasmosis by differential mechanisms. J. Immunol. 1998;160:6072-6082.
8. Deepe GS Jr, Gibbons R, Woodward E. Neutralization of endogenous granulocyte-macrophage colony-stimulating factor subverts the protective immune response to Histoplasma capsulatum. J. Immunol. 1999;163:4985-4993.
9. Smith JG, Magee DM, Williams DM, Graybill JR. Tumor necrosis factor-α plays a role in host defense against Histoplasma capsulatum. J. Infect. Dis. 1990;162:1349-1353.
10. Wu-Hsieh BA, Lee GS, Franco M, Hofman FM. Early activation of splenic macrophages by tumor necrosis factor alpha is important in determining the outcome of experimental histoplasmosis in mice. Infect. Immun. 1992;60:4230-4238.
11. Zhou P, Miller G, Seder RA. Factors involved in regulating primary and secondary immunity to infection with Histoplasma capsulatum: TNF-α plays a critical role in maintaining secondary immunity in the absence of IFN-γ. J. Immunol. 1998;160:1359-1368.
12. Zhou P, Sieve MC, Bennett J, Kwon-Chung KJ, Tewari RP, Gazzinelli RT, Sher A, Seder RA. IL-12 prevents mortality in mice infected with Histoplasma capsulatum through induction of IFN-γ. J. Immunol. 1995;155:785-795.
13. Worsham PL, Goldman WE. Quantitative plating of Histoplasma capsulatum without addition of conditioned medium or siderophores. J. Med. Vet. Mycol. 1988;26:137-143.
14. Cain JA, Deepe GS Jr. Evolution of the primary immune response to Histoplasma capsulatum in murine lung. Infect. Immun. 1998; 66:1473-1481.
15. Allendoerfer R, Boivin GP, Deepe GS Jr. Modulation of immune responses in murine pulmonary histoplasmosis. J. Infect. Dis. 1997;175:905-914.
16. Wheat LJ, Slama TG, Norton JA, Kohler RB, Eitzen HB, French ML, Sathapatayavongs B. Risk factors for disseminated or fatal histoplasmosis. Analysis of a large urban outbreak. Ann. Intern. Med. 1982;96:159-163.
17. Brummer E, Kurita N, Yosihida S, Nishimura K, Miyaji M. Fungistatic activity of human neutrophils against Histoplasma capsulatum: correlation with phagocytosis. J. Infect. Dis. 1991;164: 158-162.
18. Newman SL, Gootee L, Gabay JE. Human neutrophil-mediated fungistasis against Histoplasma capsulatum. Localization of fungistatic activity to the azurophil granules. J. Clin. Invest. 1993;92: 624-631.
19. Bullock WE, Wright SD. Role of the adherence-promoting receptors, CR3, LFA-1, and p150,95, in binding of Histoplasma capsulatum by human macrophages. J. Exp. Med. 1987;165: 195-210.
20. Newman SL, Bucher C, Rhodes J, Bullock WE. Phagocytosis of Histoplasma capsulatum yeasts and microconidia by human cultured macrophages and alveolar macrophages. Cellular cytoskeleton requirement for attachment and ingestion. J. Clin. Invest. 1990;85:223-230.
21. Wu-Hsieh BA, Howard DH. Intracellular growth inhibition of Histoplasma capsulatum induced in murine macrophages by recombinant gamma interferon is not due to a limitation of the supply of methionine or cysteine to the fungus. Infect. Immun. 1992; 60:698-700.
22. Wu-Hsieh BA, Howard DH. Inhibition of the intracellular growth of Histoplasma capsulatum by recombinant murine gamma interferon. Infect. Immun. 1987;55:1014-1016.
23. Brummer E, Stevens DA. Effect of macrophage colony-stimulating factor (M-CSF) on macrophage morphology, phagocytosis, and intracellular multiplication of Histoplasma capsulatum. Int. J. Immunopharmacol. 1994;16:171-176.
24. Deepe GS Jr, Gibbons RS. T cells require tumor necrosis factor-α to provide protective immunity in mice infected with Histoplasma capsulatum. J. Infect. Dis. 2006;193:322-330.
25. Deepe GS Jr, McGuinness M. Interleukin-1 and host control of pulmonary histoplasmosis. J. Infect. Dis. 2006;194:855-864.